Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bristol-Myers Squibb

    NYSE: BMY · Real-Time Price · USD
    48.55
    -1.20 (-2.41%)
    At close: Jun 16, 2025, 3:59 PM
    48.80
    0.51%
    After-hours: Jun 16, 2025, 07:02 PM EDT

    Bristol-Myers Squibb Statistics

    Share Statistics

    Bristol-Myers Squibb has 2.04B shares outstanding. The number of shares has increased by 0.38% in one year.

    Shares Outstanding

    n/a
    		 2.04B

    Shares Change (YoY)

    n/a
    		 0.38%

    Shares Change (QoQ)

    n/a
    		 0.32%

    Owned by Institutions (%)

    n/a
    		 78.49%

    Shares Floating

    n/a
    		 2.03B

    Failed to Deliver (FTD) Shares

    n/a
    		 34,220

    FTD / Avg. Volume

    n/a
    		 0.24%

    Short Selling Information

    The latest short interest is 32.54M, so 1.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 32.54M

    Short % of Shares Out

    n/a
    		 1.6%

    Short % of Float

    n/a
    		 1.6%

    Short Ratio (days to cover)

    n/a
    		 2.65

    Valuation Ratios

    The PE ratio is -12.81 and the forward PE ratio is 8.36. Bristol-Myers Squibb's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -12.81

    Forward PE

    n/a
    		 8.36

    PS Ratio

    n/a
    		 2.37

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 7.02

    P/FCF Ratio

    n/a
    		 8.22

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Bristol-Myers Squibb.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.25, with a Debt / Equity ratio of 3.13.

    Current Ratio

    n/a
    		 1.25

    Quick Ratio

    n/a
    		 1.15

    Debt / Equity

    n/a
    		 3.13

    Debt / EBITDA

    n/a
    		 15.91

    Debt / FCF

    n/a
    		 3.67

    Interest Coverage

    n/a
    		 3.02

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,416,422.29

    Profits Per Employee

    n/a
    		 $-262,404.69

    Employee Count

    n/a
    		 34,100

    Asset Turnover

    n/a
    		 0.52

    Inventory Turnover

    n/a
    		 5.46

    Taxes

    Income Tax

    n/a
    		 554M

    Effective Tax Rate

    n/a
    		 -6.61%

    Stock Price Statistics

    The stock price has increased by 20.7% in the last 52 weeks. The beta is 0.39, so Bristol-Myers Squibb's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.39

    52-Week Price Change

    n/a
    		 20.7%

    50-Day Moving Average

    n/a
    		 49.1

    200-Day Moving Average

    n/a
    		 54.19

    Relative Strength Index (RSI)

    n/a
    		 55.51

    Average Volume (20 Days)

    n/a
    		 14,529,279

    Income Statement

    In the last 12 months, Bristol-Myers Squibb had revenue of 48.3B and earned -8.95B in profits. Earnings per share was -4.41.

    Revenue

    n/a
    		 48.3B

    Gross Profit

    n/a
    		 34.33B

    Operating Income

    n/a
    		 5.89B

    Net Income

    n/a
    		 -8.95B

    EBITDA

    n/a
    		 3.22B

    EBIT

    n/a
    		 -6.43B

    Earnings Per Share (EPS)

    n/a
    		 -4.41
    Full Income Statement

    Balance Sheet

    The company has 10.35B in cash and 51.2B in debt, giving a net cash position of -40.85B.

    Cash & Cash Equivalents

    n/a
    		 10.35B

    Total Debt

    n/a
    		 51.2B

    Net Cash

    n/a
    		 -40.85B

    Retained Earnings

    n/a
    		 14.91B

    Total Assets

    n/a
    		 92.43B

    Working Capital

    n/a
    		 6.71B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 15.19B and capital expenditures -1.25B, giving a free cash flow of 13.94B.

    Operating Cash Flow

    n/a
    		 15.19B

    Capital Expenditures

    n/a
    		 -1.25B

    Free Cash Flow

    n/a
    		 13.94B

    FCF Per Share

    n/a
    		 6.88
    Full Cash Flow Statement

    Margins

    Gross margin is 71.08%, with operating and profit margins of 12.19% and -18.53%.

    Gross Margin

    n/a
    		 71.08%

    Operating Margin

    n/a
    		 12.19%

    Pretax Margin

    n/a
    		 -17.35%

    Profit Margin

    n/a
    		 -18.53%

    EBITDA Margin

    n/a
    		 6.66%

    EBIT Margin

    n/a
    		 12.19%

    FCF Margin

    n/a
    		 28.87%

    Dividends & Yields

    BMY pays an annual dividend of $3.04, which amounts to a dividend yield of 4.41%.

    Dividend Per Share

    n/a
    		 $3.04

    Dividend Yield

    n/a
    		 4.41%

    Dividend Growth (YoY)

    n/a
    		 3.33%

    Payout Ratio

    n/a
    		 111.36%

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BMY is $59, which is 18.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $59

    Price Target Difference

    n/a
    		 18.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 16
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 7, 2001. It was a forward split with a ratio of 1000000:951777.

    Last Split Date

    n/a
    		 Aug 7, 2001

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 1000000:951777

    Scores

    Altman Z-Score

    n/a
    		 1.9

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist